LNCaP prostate cells are broadly utilized as an AR sensitivity model in vitro but due to a low engraftment rate of 50% or less in mouse it is not fully utilized in vivo. In contrast, Hera BioLabs OncoRat SRG displays 100% engraftment rates with consistent growth kinetics. The OncoRat also enables serial blood draws and a smooth transition from efficacy to safety. We are now offering More Reliable, Robust and more Efficient in vivo LNCaP services.
Ask us about pilots, full efficacy studies or getting OncoRat in your facility.